![David G. Matthews](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David G. Matthews
Directeur Financier/CFO chez
XORTX Pharma Corp.
Profil
David G.
Matthews currently works at XORTX Pharma Corp., as Chief Financial Officer from 2018.
Mr. Matthews also formerly worked at Aspreva Pharmaceuticals Corp., as Finance Director, BMO Capital Partners, as Director, Many Bright Ideas Technologies, Inc., as Director, Chief Financial & Accounting Officer in 2010, Aspreva Pharmaceuticals SA, as Managing Director, Nventa Biopharmaceuticals Corp., as Chief Financial Officer, Allelix Biopharmaceuticals, Inc., as Chief Financial Officer, Veracyte SD, Inc., as Chief Financial Officer, and XORTX Therapeutics, Inc., as Chief Financial Officer in 2018.
Mr. Matthews received his Masters Business Admin degree from Clarkson University.
Postes actifs de David G. Matthews
| Sociétés | Poste | Début |
|---|---|---|
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology Produces biopharmaceutical products | Directeur Financier/CFO | 28/02/2018 |
Anciens postes connus de David G. Matthews
| Sociétés | Poste | Fin |
|---|---|---|
| XORTX THERAPEUTICS INC. | Directeur Financier/CFO | 06/11/2018 |
BMO Capital Partners
 BMO Capital Partners Investment ManagersFinance BMO Capital invests in middle market companies located in the Canada. The firm focuses on a broad range of sectors and industries. It participates in buyout, subordinated debt & equity and growth stage capital transactions. | Directeur/Membre du Conseil | - |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Directeur Financier/CFO | - |
Aspreva Pharmaceuticals SA
 Aspreva Pharmaceuticals SA Aspreva Pharmaceuticals SA is not mentioned in the provided summaries. The company is based in Neuchâtel, Switzerland. | President | - |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | - |
Formation de David G. Matthews
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Allelix Biopharmaceuticals, Inc.
 Allelix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and neuropharmaceuticals | Health Technology |
Clarkson University
 Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BMO Capital Partners
BMO Capital Partners Investment ManagersFinance BMO Capital invests in middle market companies located in the Canada. The firm focuses on a broad range of sectors and industries. It participates in buyout, subordinated debt & equity and growth stage capital transactions. | Finance |
Many Bright Ideas Technologies, Inc.
 Many Bright Ideas Technologies, Inc. Medical/Nursing ServicesHealth Services Develops genetic content for molecular diagnostic tests | Health Services |
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
Aspreva Pharmaceuticals SA
Aspreva Pharmaceuticals SA Aspreva Pharmaceuticals SA is not mentioned in the provided summaries. The company is based in Neuchâtel, Switzerland. | |
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology Produces biopharmaceutical products | Health Technology |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
